Summit Securities Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,400
Closed -$489K 1053
2024
Q4
$489K Hold
3,400
0.1% 138
2024
Q3
$506K Buy
+3,400
New +$488K 0.13% 98

Other funds holding RGEN

Summit Securities Group's RGEN Position: Q2 2026 in Review

Summit Securities Group opened a new position in Repligen (RGEN) in Q2 2026: 400 shares worth $54.6K. The stake represents 0.01% of the portfolio and ranks #570 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in RGEN as recently as Q1 2025.

Summit Securities Group first reported a position in RGEN in Q1 2025 and has held it in 2 quarters since. The position peaked at $165K in Q1 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Summit Securities Group held 400 shares of Repligen worth $54.6K as of Q2 2026.
  • Repligen was a new Summit Securities Group position in Q2 2026.
  • Repligen made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #570 holding.
  • Summit Securities Group first reported a position in Repligen in Q1 2025 and has held it in 2 quarters since.
  • Summit Securities Group's Repligen position peaked at $165K in Q1 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.